Exposing Cannabis Regulatory Exploitation in Portugal’s Medicinal Sector

By João L. Carapinha

June 30, 2026

cannabis regulatory exploitation

Portugal’s medicines regulator INFARMED has been shaken by a major case of cannabis regulatory exploitation in which criminal networks weaponised medicinal cannabis licences to traffic drugs on an industrial scale. Insufficient inspectors, rapid sector growth and the recruitment of former agency staff by suspect companies created perfect conditions for diversion, resulting in charges against 13 individuals and 11 companies after police seized more than 7.3 tonnes of cannabis and 500 kg of synthetic cathinones.

Revolving Door Weakens Enforcement

Former INFARMED inspectors joining investigated firms sat at the heart of the cannabis regulatory exploitation. With only three inspectors responsible for the entire national cannabis portfolio while licence numbers doubled from roughly 3,500 to 7,000 in two years, genuine oversight became impossible. Prosecutors found the agency could not verify whether declared exports to Africa ever reached their destinations or were redirected during European transit stops.

Licences Used as Criminal Cover

A sophisticated network exploited falsified certificates, precursor chemicals imported from India and Malaysia, and cryptocurrency payments exceeding $30 million. The operation, dismantled in 2025 under “Operação Erva Daninha”, ran a clandestine laboratory in Abrantes that masqueraded as legitimate medicinal cannabis production. INFARMED’s documented shortcomings provided the perfect façade for trafficking, document fraud and money laundering.

Policy Response Gains Momentum

Portuguese authorities have since increased inspections, joined the United Nations Office on Drugs and Crime tracking platform and begun revising the medicinal cannabis framework in coordination with judicial police and addiction prevention services. These measures aim to close the very gaps that enabled this cannabis regulatory exploitation and to restore confidence in regulated supply chains for therapeutic products.

Bibliography

The following sources were consulted:

  1. Franco, H., & Gustavo, R. (2026, June 30). Inspetores do Infarmed contratados por empresas investigadas por tráfico internacional de canábis. Expresso. https://expresso.pt/seguranca/2026-06-30-inspetores-do-infarmed-contratados-por-empresas-investigadas-por-trafico-internacional-de-canabis-72a60958
  2. Executive Digest. (2026, June 30). Inspetores do Infarmed foram contratados por empresas investigadas por tráfico internacional de canábis medicinal. https://executivedigest.sapo.pt/inspetores-do-infarmed-foram-contratados-por-empresas-investigadas-por-trafico-internacional-de-canabis-medicinal/
  3. Observador. (2026, June 28). Cripto, químicos da Índia e falsificações de licenças. Como uma rede de falsa canábis medicinal enganou o Infarmed para traficar droga. https://observador.pt/especiais/cripto-quimicos-da-india-e-falsificacoes-de-licencas-como-uma-rede-de-falsa-canabis-medicinal-enganou-o-infarmed-para-traficar-droga/
  4. Jornal de Notícias. (2026, June 13). Falhas do Infarmed usadas para desviar canábis medicinal para o tráfico. https://www.jn.pt/justica/artigo/falhas-do-infarmed-usadas-para-desviar-canabis-medicinal-para-o-trafico/18094699
  5. Expresso. (2026, June 13). Infarmed não tinha meios humanos para fiscalizar toneladas de canábis medicinal, conclui Ministério Público. https://expresso.pt/justica/2026-06-13-infarmed-nao-tinha-meios-humanos-para-fiscalizar-toneladas-de-canabis-medicinal-conclui-ministerio-publico-a42b600d
  6. ZAP. (2026, June 13). Toneladas de canábis medicinal desviadas para tráfico graças a falha do Infarmed. https://zap.aeiou.pt/canabis-medicinal-desviada-infarmed-748568
  7. Polícia Judiciária. (2025, May 20). Operação “Erva Daninha” – PJ desmantela grupo criminoso internacional dedicado ao tráfico de droga. Official statement. https://www.policiajudiciaria.pt/operacao-erva-daninha-pj-desmantela-grupo-criminoso-internacional-dedicado-ao-trafico-de-droga/
  8. ECO. (2025, May 20). “Erva Daninha”. Mega operação da PJ faz buscas em empresas de canábis para fins medicinais. https://eco.sapo.pt/2025/05/20/mega-operacao-da-pj-faz-buscas-em-empresas-de-canabis-para-fins-medicinais/
  9. INFARMED. (2026). Canábis para fins medicinais – Official information page (including lists of authorized entities and regulatory updates). https://www.infarmed.pt/web/infarmed/canabis-medicinal
Reference url

Recent Posts

FDA Approval Lumvoa Therapeutics
FDA Approval Lumvoa Therapeutics Redefines Treatment Landscape for Thyroid Eye Disease

By João L. Carapinha

June 29, 2026

The FDA Approval Lumvoa Therapeutics delivers the first full insulin-like growth factor-1 receptor (IGF-1R) antagonist for thyroid eye disease (TED), a rare autoimmune condition that triggers orbital inflammation, proptosis, diplopia, pain, and risk of vision loss.
HIV Treatment Access
Public-Private Partnership Enhances HIV Treatment Access Through Innovative Drug Integration

By João L. Carapinha

June 29, 2026

A new agreement between Merck and the ADAP Crisis Task Force significantly advances HIV Treatment Access by integrating the newly approved single-tablet regimen IDVYNSO™ (doravirine/islatravir) into state AIDS Drug Assistance Programs that served more than 250,000 people with HIV in 2024.
EMA CHMP Meeting Highlights
Regulatory Insights from EMA CHMP Meeting Highlights

By HEOR Staff Writer

June 26, 2026

The EMA CHMP Meeting Highlights from 22-25 June 2026 show the committee advancing six new medicines while maintaining rigorous evidentiary standards for complex and rare conditions. Positive opinions covered an inactivated influenza vaccine for adults 50 and older, a levodopa-carbidopa intestinal...